This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page


Turkey is on its way to becoming a regional power in the pharmaceutical sector thanks to 
its increasing dynamic population, powerful internal production capacity, geographical/cultural 
location and high-quality work force. The demand for generic and branded products are 
expected to increase with the support given to R&D investments in this area, incentives for 
increasing the use of generic products and the adoption of regulations on general health 

Companies in the pharmaceutical sector need to continuously be aware of change in order 
to keep their high value-added innovative structure sustainable as well as to increase their 
profitability in the evolving and highly dynamic landscape of Turkey.

Deloitte’s professionals have in-depth sectoral experience and are well versed in tax, audit, 
enterprise risk, corporate finance, and consultancy and provide a wide range of services 
tailored to the needs of large-scale local or foreign companies in the Turkish pharmaceutical 

Key Contact

  • Hülya Yılmaz
    Tel: 0 (212) 366 60 72

Contact us

  • ExternalURL
Stay connected: